Prednisone-dependent asthma: inflammatory indices in induced sputum

Area of Science:

• Pulmonology
• Immunology
• Pharmacology

Background:

• Prednisone-dependent asthma requires careful management to balance efficacy and side effects.
• Understanding inflammatory responses during prednisone dose reduction is crucial for patient care.

Purpose of the Study:

• To investigate the kinetics of inflammatory markers in induced sputum during prednisone dose reduction in prednisone-dependent asthmatics.
• To determine if sputum analysis can predict clinical exacerbations and guide minimum effective prednisone dosage.

Main Methods:

• Eight prednisone-dependent asthmatics underwent a structured prednisone dose reduction protocol.
• Induced sputum was analyzed for inflammatory cells (eosinophils, neutrophils) and mediators (ECP, fibrinogen, IL-5).
• Clinical symptoms and lung function (FEV1) were monitored throughout the study.

Main Results:

• Sputum eosinophilia increased significantly before clinical exacerbations, worsening symptoms, and decreased FEV1.
• Increases in sputum eosinophils preceded blood eosinophil increases by 4 weeks.
• Prednisone treatment suppressed sputum eosinophilia and ECP but did not affect neutrophils, fibrinogen, or IL-5.

Conclusions:

• Prednisone dose reduction in dependent asthmatics elicits a pronounced airway eosinophilic inflammatory response.
• Sputum inflammatory markers change earlier than clinical or blood indices, suggesting their utility in identifying minimal effective prednisone doses.
• Sputum analysis offers a valuable tool for optimizing prednisone therapy in this patient population.